title: Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium.
authors.affiliation: Ligand Pharmaceuticals, Inc., San Diego, California 92121, USA. anegrovilar@ligand.com
authors.forename: A
authors.initials: A
authors.lastname: Negro-Vilar
mesh_terms: D000728:Androgens / Q000737:chemistry / Q000235:genetics / Q000627:therapeutic use*; D004704:Endocrinology / Q000639:trends*; D005260:Female; D006801:Humans; D008297:Male; D011944:Receptors, Androgen / Q000378:metabolism*; D013329:Structure-Activity Relationship
chemical_list: D000728:Androgens; D011944:Receptors, Androgen